Follow
Biopharmaceutical
Biopharmaceuticals are medical drugs produced using biotechnology. They are proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) used for therapeutic or in vivo diagnostic purposes, and are produced by means other than direct extraction from a native (non-engineered) biological source. The first such substance approved for therapeutic use was recombinant human insulin.
SEP 09, 2025 | 12:00 PM
The discovery of covalent inhibitors has become a powerful strategy in drug development due to their ability to form irreversible bonds with target proteins, resulting in enhanced therapeuti...
On Demand
C.E. CREDITS
A microphysiological system is a 3D in vitro model that mimics human tissue environments with high physiological relevance. This approach enhances our understanding of disease mechanisms, dr...
JUN 04, 2024 | 11:00 AM
TBD...
MAY 29, 2024 | 8:00 AM
A-TEEM spectroscopy is an emerging technique with huge potential for QC laboratories in the pharmaceutical and biopharmaceutical industries. We present a set of tools for A-TEEM spectroscopy...
APR 30, 2024 | 2:00 PM
Cell-based therapeutics show immense promise in treating a variety of currently incurable diseases due to their potent mechanisms. However, despite recent successes, challenges persist in ma...
APR 03, 2024 | 2:00 PM
Cell and gene therapies are on the brink of transforming the pharmaceutical industry, presenting unique challenges such as ensuring the quality and consistent supply of reagents. Reagents pl...
On Demand
C.E. CREDITS
Self-removing affinity tags have the potential to greatly accelerate the development of new therapeutics, while providing a potentially enabling manufacturing platform for non-mAb therapeuti...
MAR 20, 2024 | 7:30 AM
Biopharmaceutical manufacturing of proteins requires an efficient cell line. Starting with several thousand clones, researchers use multiple selection rounds to ultimately chose one clone fo...
FEB 21, 2024 | 6:00 AM
The cancer drug discovery landscape is shifting. While research continues to grow in cost and complexity, the pace of development has never been faster. Biopharmaceutical companies can&rsquo...
DEC 05, 2023 | 3:00 PM
Most FDA-approved therapeutic drugs target transmembrane proteins, yet the development of monoclonal antibodies for multi-transmembrane protein targets has been limited. Despite the abundanc...
